Literature DB >> 4516626

Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.

W Paolino, L Resegotti, M Rossi, V Infelise.   

Abstract

A preliminary report is given of a trial of the T.R.A.P. regimen (thioguanine, rubidomycin, cytosine arabinoside, and prednisolone) for the treatment of acute myeloid leukaemia. Out of 27 patients treated 13 (48.1%) obtained complete remission. The treatment was well tolerated and produced especially good results in elderly patients.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4516626      PMCID： PMC1586843          DOI： 10.1136/bmj.3.5880.567

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  3 in total

1.  Management of adult acute myelogenous leukaemia.

Authors:  D Crowther; R L Powles; C J Bateman; M E Beard; C L Gauci; P F Wrigley; J S Malpas; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1973-01-20

2.  Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.

Authors:  J P Whitecar; G P Bodey; E J Freireich; K B McCredie; J S Hart
Journal:  Cancer Chemother Rep       Date:  1972-08

3.  Treatment of adult acute leukemia with arabinosylcytosine and thioguanine.

Authors:  T S Gee; K P Yu; B D Clarkson
Journal:  Cancer       Date:  1969-05       Impact factor: 6.860
  3 in total
  1 in total

1.  Blood and neoplastic diseases. Acute myeloblastic leukaemia.

Authors:  M L Willoughby
Journal:  Br Med J       Date:  1974-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.